Clinical Trial Update: Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trials evaluating intravenous granulocyte colony-stimulating factor (G-CSF) with autologous peripheral blood stem cells for neurore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Neurodegenerative Disease

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: Neurodegeneration, G-CSF | Phase 1, Phase 2 | Status: COMPLETED